Amer Sports, Inc. (AS) stock analysis, February 25, 2026: Strong FY2025 sales, but Q1 margin guidance misses by 180 bps — can $37.51 hold?

Key Updates

Amer Sports declined 2.55% to $37.51 since the February 24 report, extending losses for a seventh consecutive session and falling 9.20% over the past five trading days. The stock now trades 7.82% below its six-month high despite remaining marginally positive YTD at +0.43%. The company delivered strong FY2025 results with 27% revenue growth to $6.6 billion and adjusted operating margin expansion to 12.8%, but issued disappointing Q1 2026 guidance that triggered an 8.6% premarket drop on February 24. Management projects Q1 adjusted EPS of $0.28-0.30 versus consensus of $0.33 and adjusted operating margins of 14-14.5% versus expected 16.2%, reflecting increased investments in Salomon footwear promotion that compressed margins despite robust top-line performance.

Current Trend

Amer Sports has entered a pronounced downtrend, declining 9.20% over five days and breaking below the critical $40 support level that had provided technical stability since mid-February. The stock now trades at $37.51, representing a 7.82% decline from six-month highs and testing support in the $37-38 range. YTD performance remains barely positive at +0.43%, a dramatic reversal from the momentum established in January. The seven-session losing streak represents the longest consecutive decline since the IPO period, with daily losses accelerating from -2.04% to -5.35% to -2.55% across the past three reports. Volume patterns suggest institutional selling pressure following the disappointing Q1 guidance, with the stock unable to find support despite delivering strong FY2025 results that exceeded analyst expectations.

Investment Thesis

The investment thesis centers on Amer Sports' transformation into a premium athletic and outdoor brand conglomerate, driven by flagship brand Arc'teryx and the resurgent Salomon, which surpassed $2 billion in annual sales. The company has demonstrated exceptional execution with 27% revenue growth in FY2025, 150+ basis points of operating margin expansion, and strong cash generation exceeding $700 million. The strategic focus on direct-to-consumer channels, geographic expansion particularly in Asia, and product innovation across categories positions the portfolio for sustained double-digit growth. Management's FY2026 guidance of 16-18% revenue growth and adjusted EPS of $1.10-1.15 implies continued momentum, supported by a fortress balance sheet with only $291 million in net debt. The appointment of Carrie Ask as Wilson Brand President effective March 1, 2026, signals leadership renewal to accelerate the turnaround of underperforming segments. However, the thesis now faces near-term pressure from margin compression as the company invests aggressively in Salomon footwear marketing to capture market share in the competitive running category.

Thesis Status

The long-term investment thesis remains intact but faces meaningful near-term headwinds that have triggered a valuation reset. While FY2025 results validated the growth trajectory with Arc'teryx and Salomon delivering exceptional performance, the Q1 2026 guidance reveals the cost of accelerating Salomon's footwear expansion. The projected 14-14.5% Q1 operating margin represents approximately 180 basis points of compression versus analyst expectations, indicating management is prioritizing market share gains over near-term profitability. This strategic trade-off is defensible given the $383.88 billion global sports apparel market opportunity growing at 6.7% CAGR through 2032, but creates execution risk as the company navigates intensifying competition from established players and emerging brands. Additional concerns include potential warm weather impact on Arc'teryx winter sales in China and lingering reputational issues from the Himalayan fireworks controversy. The thesis requires monitoring whether increased marketing investments translate to sustainable market share gains and whether margin pressure proves transitory or structural as the company scales Salomon footwear against Nike, Adidas, and specialist brands like On Running and Hoka.

Key Drivers

The primary driver is Amer Sports' Q1 2026 guidance miss, with adjusted EPS of $0.28-0.30 falling 9% below consensus and operating margins 180 basis points below expectations due to increased Salomon footwear marketing investments. Despite this, FY2025 results demonstrated strong execution with Q4 revenue up 28% to $2.1 billion and full-year revenue reaching $6.6 billion, validating the multi-brand strategy. The broader industry context shows global sports apparel market projected to reach $383.88 billion by 2032 with 6.7% CAGR, supporting long-term growth prospects. However, competitive intensity is escalating as Anta Sports expands its portfolio through the $1.8 billion Puma acquisition, creating a formidable competitor with combined scale and China market access. Leadership changes also factor in, with Carrie Ask appointed Wilson Brand President effective March 1, 2026, signaling management's commitment to revitalizing underperforming brands.

Technical Analysis

Amer Sports has broken critical technical support, declining from $40.66 to $37.51 over the past two sessions and establishing a clear downtrend. The stock failed to hold the $40 level that had provided support since mid-February, triggering accelerated selling that pushed shares through the $38 psychological level. The seven-session losing streak represents the most sustained selling pressure since the IPO, with cumulative losses exceeding 9% over five days. Volume patterns indicate institutional distribution rather than retail capitulation, suggesting professional investors are repositioning following the guidance disappointment. The stock now tests support in the $37-38 range, with next meaningful support likely at $35-36 based on prior consolidation levels. Resistance has formed at $40, which must be reclaimed to signal trend reversal. The YTD gain of just 0.43% has evaporated from mid-single-digit positive territory two weeks ago, indicating momentum has shifted decisively bearish. The declining 5-day and 1-month performance metrics (-9.20% and -0.95% respectively) confirm deteriorating technical conditions that typically require multiple sessions of stabilization before reversal patterns can develop.